2023 annual financial data
Aprea Therapeutics 2023 Operating margin
Direct answer
Operating margin was -2,652.8%.
Operating income was -15,471,963 USD and net income was -14,286,756 USD.
Operating cash flow was -12,177,608 USD.
Get free Aprea Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 583,231 USD
- Operating income
- -15,471,963 USD
- Net income
- -14,286,756 USD
- Operating cash flow
- -12,177,608 USD